In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...
It took another year for the FDA to grant interchangeability status to Rezvoglar, meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without needing a separate ...
California Governor Gavin Newsom's bold plan to produce cheap, generic insulin for Californians by 2024 could be delayed for years. Civica, the nonprofit drug manufacturer contracted to produce ...
meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without needing a separate prescription. The length of time it takes for a company to develop a drug ...